CHRNA5 Variant Predicts Smoking Cessation in Patients With Acute Myocardial Infarction | Zendy

LiShiun Chen | Zendy; Richard G. Bach | Zendy; Petra Lenzini | Zendy; John A. Spertus | Zendy; Laura J. Bierut | Zendy; Sharon Cresci | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CHRNA5 Variant Predicts Smoking Cessation in Patients With Acute Myocardial Infarction

Author(s) -

LiShiun Chen,

Richard G. Bach,

Petra Lenzini,

John A. Spertus,

Laura J. Bierut,

Sharon Cresci

Publication year - 2014

Publication title -

nicotine and tobacco research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.338

H-Index - 113

eISSN - 1469-994X

pISSN - 1462-2203

DOI - 10.1093/ntr/ntu059

Subject(s) - smoking cessation , medicine , myocardial infarction , pathology

While smoking is a major modifiable risk factor for secondary prevention of myocardial infarction (MI), active smoking is common among patients hospitalized with acute MI. Recent studies suggest that nicotinic receptor variants, and specifically the high-risk CHRNA5 rs16969968 A allele, are associated with cessation failure among noncardiac patients. This study investigates the association between CHRNA5 rs16969968 and smoking cessation in patients hospitalized with acute MI.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research